Processa Pharmaceuticals Competitors and Similar CompaniesClear all

Nektar Therapeutics's competitors and similar companies include Takeda and Exelixis.
Nektar Therapeutics
Nektar Therapeutics
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
Takeda
Takeda
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
Exelixis
Exelixis
Exelixis is an oncology company that develops cancer treatments.
Founding Date
Founding Date
1990
Founding Date
1781
Founding Date
1994
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Francisco, US HQ
Hyderabad, IN
Huntsville, US
Locations
Tokyo, JP HQ
Buenos Aires, AR
The Rocks, AU
Linz, AT
Wien, AT
Wien, AT
Lessines, BE
see more
Locations
Alameda, US HQ
Employees
Employees
61821% increase
Employees
47,4554% decrease
Employees
1,14712% decrease
Valuation ($)
Valuation ($)
233.8 m
Valuation ($)
43.7 b
Valuation ($)
8.2 b

Financial

Revenue (est.)
Revenue (est.)
$55.2m (FY, 2025)
Revenue (est.)
¥4.5t (FY, 2026)
Revenue (est.)
$2.3b (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
¥850.5b (FY, 2026)
Cost of goods
$83.7m (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
¥3.7t (FY, 2026)
Gross profit
$2.2b (FY, 2025)
Net income
Net income
($164.1m) (FY, 2025)
Net income
¥192b (FY, 2026)
Net income
$782.6m (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 45m
Total funding raised
$ 57.8m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Takeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease

Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.

View company
Exelixis
HQ
Alameda, US
Employees
1,147↓ 12% decrease

Exelixis is an oncology company that develops cancer treatments.

View company